Allogeneic human umbilical cord blood for acute ischemic stroke: Phase I clinical trial

20251 citationsJournal Articlediamond Open Access

Authors

Raymond Y. Lo · Tzu Chi Foundation

Y.-H. Luo · National Yang Ming Chiao Tung University

Shu‐Cin Chen · Tzu Chi Foundation

Jen-Hung Wang · StemCyte

Chen-Yu Ko · Stem Cell Technology (Taiwan)

Yingjie Chen · Stem Cell Technology (Taiwan)

Yu-Chin Su ·

Abstract

The IV hUCB was safe and well tolerated in AIS patients, and the preliminary efficacy results demonstrated its therapeutic potential, supporting the conduct of a randomized, placebo controlled, phase II clinical trial in future.

Topics & Keywords

Acute Ischemic Stroke Management Neuroinflammation and Neurodegeneration Mechanisms Mesenchymal stem cell research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Tzu Chi Medical Journal

Volume 37, Issue 3, pp. 321-327

DOI: 10.4103/tcmj.tcmj_249_24

Field-Weighted Citation Impact: 1.41